| Transcriptional regulation of cancer immune checkpoints: emerging strategies for immunotherapy S Venkatraman, J Meller, S Hongeng, R Tohtong, S Chutipongtanate Vaccines 8 (4), 735, 2020 | 26 | 2020 |
| Effect of combining EGFR tyrosine kinase inhibitors and cytotoxic agents on cholangiocarcinoma cells B Boonsri, K Yacqub-Usman, P Thintharua, KZ Myint, T Sae-Lao, P Collier, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2021 | 11 | 2021 |
| Co-clinical trials: an innovative drug development platform for cholangiocarcinoma B Balasubramanian, S Venkatraman, KZ Myint, T Janvilisri, ... Pharmaceuticals 14 (1), 51, 2021 | 10 | 2021 |
| Targeting MYC at the intersection between cancer metabolism and oncoimmunology S Venkatraman, B Balasubramanian, C Thuwajit, J Meller, R Tohtong, ... Frontiers in Immunology 15, 1324045, 2024 | 9 | 2024 |
| Molecularly guided drug repurposing for cholangiocarcinoma: an integrative bioinformatic approach S Venkatraman, B Balasubramanian, P Pongchaikul, R Tohtong, ... Genes 13 (2), 271, 2022 | 9 | 2022 |
| RTK25: A comprehensive molecular profiling strategy in cholangiocarcinoma using an integrated bioinformatics approach B Balasubramanian, S Venkatraman, T Janvilisri, T Suthiphongchai, ... Pharmaceuticals 14 (9), 898, 2021 | 7 | 2021 |
| Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells K Islam, B Balasubramanian, S Venkatraman, P Thummarati, ... Scientific Reports 13 (1), 22598, 2023 | 5 | 2023 |
| Targeting FGFRs using PD173074 as a novel therapeutic strategy in cholangiocarcinoma B Balasubramanian, K Yacqub-Usman, S Venkatraman, KZ Myint, ... Cancers 15 (9), 2528, 2023 | 4 | 2023 |
| Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker. K Islam, B Balasubramanian, S Venkatraman, J Puetkasichonpasutha, ... ScienceAsia 48 (4), 2022 | 2 | 2022 |
| In silico target identification of galangin, as an herbal flavonoid against cholangiocarcinoma B Balasubramanian, S Venkatraman, KZ Myint, S Krobthong, ... Molecules 27 (14), 4664, 2022 | 2 | 2022 |
| Therapeutic implications of ceritinib in cholangiocarcinoma beyond ALK expression and mutation KZ Myint, B Balasubramanian, S Venkatraman, S Phimsen, S Sripramote, ... Pharmaceuticals 17 (2), 197, 2024 | 1 | 2024 |
| Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma KZ Myint, M Sueca-Comes, P Collier, B Balasubramanian, ... Frontiers in Oncology 13, 1184900, 2023 | 1 | 2023 |
| FGF signalling as a therapeutic target in Cholangiocarcinoma B Balasubramanian, KZ Myint, K Yacqub-Usman, S Venkatraman, ... Cancer Science 112, 419-419, 2021 | 1 | 2021 |
| Identification of Transcriptional Regulators of Immune Evasion Across Cancers: An Alternative Immunotherapeutic Strategy for Cholangiocarcinoma S Venkatraman, B Balasubramanian, P Kongpracha, S Yangngam, ... Cancers 16 (24), 4197, 2024 | | 2024 |
| Author Correction: Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial-to-mesenchymal transition of cholangiocarcinoma cells K Islam, B Balasubramanian, S Venkatraman, P Thummarati, ... Scientific Reports 14, 21696, 2024 | | 2024 |
| Cell Model Representatives of Pediatric Neuroblastoma: Evidence from Transcriptomic Ranking and Pharmacogenomic Connectivity Analysis S Venkatraman, P Pongchaikul, B Balasubramanian, P Vivitthanaporn, ... | | 2024 |
| Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn … T Suthiphongchai | | 2024 |
| Acknowledgment to the Reviewers of Genes in 2022 Genes Office Editorial Genes 14 (2), 238, 2023 | | 2023 |
| Acknowledgment to the Reviewers of BioMedInformatics in 2022 BioMedInformatics Editorial Office BioMedInformatics 3 (1), 102-103, 2023 | | 2023 |
| Acknowledgment to the Reviewers of Genes in 2022 A Garcia-Ruiz, A Gijsbers, AKMM Huque, AH Mossa, AMA Ahmed, ... | | 2023 |
Brinda BalasubramanianUniversity of NottinghamEmail verificata su nottingham.ac.uk